Literature DB >> 16565733

Blockade of IKs by HMR 1556 increases the reverse rate-dependence of refractoriness prolongation by dofetilide in isolated rabbit ventricles.

Petsy Pui-Sze So1, Xu-Dong Hu, Peter H Backx, José Luis Puglisi, Paul Dorian.   

Abstract

1. The rate-dependent contributions of the rapid and slow components of the cardiac delayed rectifier K+ current (IKr and IKs, respectively) to repolarization are not fully understood. It is unclear whether the addition of IKs block will attenuate reverse rate-dependence seen after IKr block. 2. The individual and combined electrophysiological effects of selective IKr and IKs blockers, dofetilide and HMR 1556, respectively, were evaluated using Langendorff-perfused rabbit hearts. Monophasic action potential duration at 90% repolarization (MAPD90) and ventricular effective refractory period (VERP) were determined at cycle lengths (CLs) of 200-500 ms (at 50 ms intervals). 3. Dofetilide (1-100 nM) prolonged MAPD90 in a concentration-dependent manner (P < 0.001, n = 6) with reverse rate-dependence (P < 0.0001). In contrast, HMR 1556 (10-240 nM) alone did not prolong MAPD90. However, in the presence of 7.5 nM dofetilide, HMR 1556 (100 nM) increased the extent of reverse rate-dependence by further prolonging MAPD90 at CLs of 400, 450 and 500 ms (P < 0.05, n = 9) and, to a lesser extent, at shorter CLs (e.g. by 17 +/- 4 ms at CL 500 vs 2 +/- 3 ms at CL 200 ms). 4. Effects of dofetilide and HMR 1556 on VERP were similar to those on MAPD90. The slope of the VERP vs CL relation was steeper after the combination (0.081 +/- 0.013) than after dofetilide alone (0.028 +/- 0.018, P < 0.01, n = 9). 5. Blockade of rabbit IKs increased reverse rate-dependence of IKr block.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565733      PMCID: PMC1751568          DOI: 10.1038/sj.bjp.0706721

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

Review 1.  Current status of monophasic action potential recording: theories, measurements and interpretations.

Authors:  M R Franz
Journal:  Cardiovasc Res       Date:  1999-01       Impact factor: 10.787

2.  Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide.

Authors:  E Carmeliet
Journal:  J Pharmacol Exp Ther       Date:  1992-08       Impact factor: 4.030

3.  Protecting the heart against arrhythmias: potassium current physiology and repolarization reserve.

Authors:  Dan M Roden; Tao Yang
Journal:  Circulation       Date:  2005-09-06       Impact factor: 29.690

Review 4.  Potassium channel down-regulation in heart failure.

Authors:  M Näbauer; S Kääb
Journal:  Cardiovasc Res       Date:  1998-02       Impact factor: 10.787

5.  The slow component of the delayed rectifier potassium current in undiseased human ventricular myocytes.

Authors:  L Virág; N Iost; M Opincariu; J Szolnoky; J Szécsi; G Bogáts; P Szenohradszky; A Varró; J G Papp
Journal:  Cardiovasc Res       Date:  2001-03       Impact factor: 10.787

6.  Heterogeneous distribution of the two components of delayed rectifier K+ current: a potential mechanism of the proarrhythmic effects of methanesulfonanilideclass III agents.

Authors:  J Cheng; K Kamiya; W Liu; Y Tsuji; J Toyama; I Kodama
Journal:  Cardiovasc Res       Date:  1999-07       Impact factor: 10.787

7.  A reinterpretation of mammalian sodium channel gating based on single channel recording.

Authors:  R W Aldrich; D P Corey; C F Stevens
Journal:  Nature       Date:  1983 Dec 1-7       Impact factor: 49.962

8.  Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.

Authors:  L M Hondeghem; D J Snyders
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

Review 9.  Two components of delayed rectifier K+ current in heart: molecular basis, functional diversity, and contribution to repolarization.

Authors:  Jian-hua Cheng; Itsuo Kodama
Journal:  Acta Pharmacol Sin       Date:  2004-02       Impact factor: 6.150

10.  Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide.

Authors:  N K Jurkiewicz; M C Sanguinetti
Journal:  Circ Res       Date:  1993-01       Impact factor: 17.367

View more
  11 in total

1.  Double pharmacological challenge on repolarization opens new avenues for drug safety research.

Authors:  M B Thomsen
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

Review 2.  Slow delayed rectifier potassium current (IKs) and the repolarization reserve.

Authors:  Norbert Jost; Julius Gy Papp; András Varró
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-01       Impact factor: 1.468

3.  Populations of in silico myocytes and tissues reveal synergy of multiatrial-predominant K+ -current block in atrial fibrillation.

Authors:  Haibo Ni; Alex Fogli Iseppe; Wayne R Giles; Sanjiv M Narayan; Henggui Zhang; Andrew G Edwards; Stefano Morotti; Eleonora Grandi
Journal:  Br J Pharmacol       Date:  2020-08-09       Impact factor: 8.739

4.  Selective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillation.

Authors:  Courtney M Campbell; Jonathan D Campbell; Christopher H Thompson; Eleonora Savio Galimberti; Dawood Darbar; Carlos G Vanoye; Alfred L George
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-09-04

5.  The anaesthetized rabbit with acute atrioventricular block provides a new model for detecting drug-induced Torsade de Pointes.

Authors:  Mihoko Hagiwara; Seiji Shibuta; Kazuhiro Takada; Ryuichi Kambayashi; Misako Nakajo; Megumi Aimoto; Yoshinobu Nagasawa; Akira Takahara
Journal:  Br J Pharmacol       Date:  2017-07-05       Impact factor: 8.739

Review 6.  Voltage-gated potassium channels as therapeutic targets.

Authors:  Heike Wulff; Neil A Castle; Luis A Pardo
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

7.  Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks).

Authors:  Joffrey Ducroq; H Moha ou Maati; S Guilbot; S Dilly; E Laemmel; C Pons-Himbert; J F Faivre; P Bois; O Stücker; M Le Grand
Journal:  Br J Pharmacol       Date:  2009-08-24       Impact factor: 8.739

8.  Potentiation of E-4031-induced torsade de pointes by HMR1556 or ATX-II is not predicted by action potential short-term variability or triangulation.

Authors:  G Michael; J Dempster; K A Kane; S J Coker
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

9.  Slow delayed rectifier K+ current block by HMR 1556 increases dispersion of repolarization and promotes Torsades de Pointes in rabbit ventricles.

Authors:  P P-S So; P H Backx; P Dorian
Journal:  Br J Pharmacol       Date:  2008-10-06       Impact factor: 8.739

10.  Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.

Authors:  C Lengyel; A Varró; K Tábori; J G Papp; I Baczkó
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.